drugset / Trial / NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics, and early clinical activity of INCB099280 in participants with select solid tumors
Timeline
- Start
- 2020-09-04
- Primary completion
- 2024-08-29
- Completion
- 2024-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCB099280 | Unknown | 25 mg | Oral |
| Subject | INCB099280 | Unknown | 100 mg | Oral |